Top Abstract Purchase Related
Home
>
Node
>
Subnode

A case of recurrent breast cancer in which gemcitabine-docetaxel therapy was successful for a long period

Kakimoto, M.; Kawashima, H.; Koshiishi, H.; Miyamoto, H.; Okamura, T.

Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2086-2087

2012

ISSN/ISBN: 0385-0684
PMID: 23267985
Document Number: 663472
This is a case of a 58-year-old woman who underwent mastectomy for advanced right breast cancer (T2N2M0, stage IIIA, ER+, PR+, and HER2 0) at another hospital 13 years ago. Tamoxifen was administered after the operation. Two years later, bone and lung metastases appeared and she was transferred to our hospital. Hormonal therapies, epirubicin- cyclophosphamide-5-FU, doxifluridine, paclitaxel, vinorelbine, and capecitabine were ineffective. We planned a sixth-line chemotherapy comprising gemcitabine combined with docetaxel, but not paclitaxel. Partial response was obtained by treatment with 3 courses of gemcitabine-docetaxel. The same treatment was continued and the patient is alive in a good condition without progression for 14 months.

Document emailed within 1 workday
Secure & encrypted payments

Sawada, Y.; Fujii, T.; Takahashi, H.; Yokoyama, G.; Matsubayashi, R.N.; Inoue, Y.; Uesugi, N.; Momosaki, S.; Toh, U.; Shirouzu, K. 2009: A case of triple negative chest wall recurrent breast cancer treated with capecitabine and docetaxel combination therapy (XT therapy) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 815-817
Nagumo, Y.; Kimura, T.; Ichioka, D.; Uchida, M.; Oikawa, T.; Suetomi, T.; Miyazaki, J.; Kawai, K.; Nagata, C.; Nishiyama, H. 2013: Long-term survival with gemcitabine and docetaxel for renal leiomyosarcoma : a case report Hinyokika Kiyo. Acta Urologica Japonica 59(8): 497-501
Vici, P.; Giotta, F.; DI Lauro, L.; Brandi, M.; Gebbia, V.; Foggi, P.; Lorusso, V.; Vitucci, C.; Sergi, D.; Fattoruso, S.I.; Giannarelli, D.; Viola, G.; Corsetti, S.; Colucci, G.; Lopez, M. 2009: Multicenter phase Ii trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines Anticancer Research 29(5): 1841-1845
Oura, S.; Tanino, H.; Yoshimasu, T.; Sakurai, T.; Nakamura, T.; Kokawa, Y.; Matsuyama, K.; Naito, Y. 2001: A case of docetaxel-resistant breast cancer responsive to paclitaxel therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(4): 511-514
Syrigos, K.N.; Konstantinou, M.; Sepsas, E.; Papamichales, G.; Loullias, A.; Belenis, I.; Skottis, I.; Charpidou, A.; Roussos, C. 2007: Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study Anticancer Research 27(4c): 2887-2892
Sunagozaka, H.; Yamashita, T.; Kagaya, T.; Kato, Y.; Kaneko, S. 2006: A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 829-832
Taguchi, T.; Mori, S.; Abe, R.; Hasegawa, K.; Morishita, Y.; Tabei, T.; Sasaki, Y.; Fujita, M.; Enomoto, K.; Hamano, K. 1994: Late phase Ii clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(15): 2625-2632
Yayoi, E.; Kobayashi, T.; Inaji, H.; Maeura, Y.; Mori, T. 1984: A case of recurrent breast cancer responding to long-term administration of tamoxifen Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1683-1686
Schneeweiss, A.; Bastert, G.; Huober, J.; Wallwiener, D.; Hamerla, R.; Lichter, P. 2004: Neoadjuvant therapy with gemcitabine in breast cancer Oncology 18(14 Suppl 12: 27-31
Oura, S.; Sakurai, T.; Yoshimura, G.; Tamaki, T.; Umemura, T.; Kokawa, Y.; Naito, Y.; Suzuma, T.; Tanino, H. 1999: Docetaxel therapy against anthracycline resistant breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(6): 781-788
Hortobágyi, G. 1997: Docetaxel in breast cancer and a rationale for combination therapy Oncology 11(6 Suppl 6: 11-15
Katsumori, T.; Hamaguchi, H.; Yamamoto, S.; Tsukamoto, Y.; Ohshima, H.; Ohkawara, S.; Shimada, S. 2016: A Case of Recurrent Inflammatory Breast Cancer Treated Using Multidisciplinary Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2054-2055
Matsutani, T.; Uchida, E.; Maruyama, H.; Suzuki, S.; Yokoyama, T.; Matsushita, A.; Hirakata, A.; Kawamoto, M.; Arai, H.; Umakoshi, M.; Wakabayashi, H.; Sasajima, K. 2010: A successful resected case of far-advanced cancer at the esophagogastric junction by chemoradiotherapy with docetaxel, nedaplatin and 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1949-1952
Tsukamoto, T.; Yonese, J.; Ishii, N.; Maezawa, T.; Fukui, I. 2002: Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report Hinyokika Kiyo. Acta Urologica Japonica 48(7): 427-430
Takizawa, M.; Hirano, M.; Murakami, N.; Uno, Y.; Kikuchi, T.; Nozawa, H.; Hara, T.; Asaumi, Y.; Kikkawa, H. 2002: A case of recurrent gastric cancer that responded dramatically to docetaxel and 5'-DFUR combination chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(9): 1647-1650
Ono, Y.; Aoyama, T.; Morita, J.; Maezawa, Y.; Amano, S.; Sawazaki, S.; Numata, M.; Tamagawa, H.; Sato, T.; Oshima, T.; Yoshikawa, T.; Ozawa, Y.; Yukawa, N.; Masuda, M.; Rino, Y. 2018: A Case of Advanced Gastric Cancer with Long-Term Survival Due to Successful Ramucirumab and Paclitaxel Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(13): 2156-2158
Ishida, K. 2013: A case of recurrent breast cancer with liver metastases showing good response to combination therapy with S-1 plus trastuzumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(10): 1385-1387
Sakuta, M.; Sumiyama, Y.; Okamoto, Y.; Noto, Y.; Naka, I.; Kiribayashi, T. 2002: A case of locally recurrent breast cancer in which phlebothrombosis of the right leg after hormonal therapy using a high dose of toremifene citrate Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(1): 115-118
Dank, M.; Zergenyi, E.; Domotori, Z.S.; Lahm, E.; Kulka, J. 2003: Primary systemic therapy (PST) of locally advanced breast cancer using Doxorubicin/Docetaxel combination Anticancer Research 23(3c): 2879-2880
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325